Postdoctoral Research Associate

Employment Type
Regular Full-Time
Requisition number
1682
Department
Kwok Lab
Location
Seattle

Overview

The Kwok Lab is a team-oriented translational research laboratory focusing on antigen specific CD4+ T cell responses in autoimmune and allergic diseases in humans.

Responsibilities

  • Will lead experiments in characterization of autoreactive T cells in Rheumatoid Arthritis.
  • Will lead experiments in identification of T cell epitopes in Rheumatoid Arthritis.
  • Will carry out bench work experiments, including assay development, cell culture, flow cytometry assays and be responsible for checking and validating the results in each field of activity.
  • Will present results or summary of results to the project team or to other audiences as needed
  • Will write required documents such as experimental procedures, research articles and study reports.
  • Provide oversight/ supervision of technicians or graduate students within the context of these studies.

Requirements

  • PhD Degree in Immunology/Biochemistry or similiar scientific discipline.
  • Knowledge in cellular immunology with less than 3 years of postdoctoral experience.
  • Specific specialization on human T and/or B cell immunology is required. Previous experience with MHC multimer staining, RNAseq, or knowledge in bioinformatics is a plus.
  • Significant experience in multi-parameter flow cytometry, and in design/set up of cell based assays.
  • Additional expertise in other laboratory techniques related to molecular biology and biochemistry research will also be considered.
  • Excellent verbal and written communication skills with good organizational and analytical abilities.

 

 

All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, citizenship, disability or protected veteran status.

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed